Gilead’s HIV treatment trials involving GS-1720 and GS-4182 have been put on clinical hold by the Food and Drug Administration.

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.

Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.

A cheese sold at Trader Joe’s in California and Nevada has been recalled due to possible listeria contamination.

Dozens of people in northeastern England have developed a rare and dangerous illness after receiving Botox injections.

Patients with ARDs who received RTX demonstrated impaired humoral responses to RZV, compared with healthy controls and individuals with ARDs not exposed to RTX.

A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

The risk for surgical site infection following hip arthroplasty was associated with male sex, BMI, operation time, diabetes, heart disease, and ASA class.

Kraft Heinz said it will stop using artificial dyes in all U.S. products by the end of 2027. The company also said it won’t use any synthetic colors in new products going forward, The Wall Street ...